Skip to main content
Journal cover image

Mesenchymal stromal cells suppress microglial activation and tumor necrosis factor production.

Publication ,  Journal Article
Xu, L; Min, H; Saha, A; Gunaratne, A; Schwartzman, J; Parrott, R; Kurtzberg, J; Filiano, AJ
Published in: Cytotherapy
February 2024

BACKGROUND AIMS: White matter diseases are commonly associated with microglial activation and neuroinflammation. Mesenchymal stromal cells (MSCs) have immunomodulatory properties and thus have the potential to be developed as cell therapy for white matter disease. MSCs interact with resident macrophages to alter the trajectory of inflammation; however, the impact MSCs have on central nervous system macrophages and the effect this has on the progression of white matter disease are unclear. METHODS: In this study, we utilized numerous assays of varying complexity to model different aspects of white matter disease. These assays ranged from an in vivo spinal cord acute demyelination model to a simple microglial cell line activation assay. Our goal was to investigate the influence of human umbilical cord tissue MSCs on the activation of microglia. RESULTS: MSCs reduced the production of tumor necrosis factor (TNF) by microglia and decreased demyelinated lesions in the spinal cord after acute focal injury. To determine if MSCs could directly suppress the activation of microglia and to develop an efficient potency assay, we utilized isolated primary microglia from mouse brains and the Immortalized MicroGlial Cell Line (IMG). MSCs suppressed the activation of microglia and the release of TNF after stimulation with lipopolysaccharide, a toll-like receptor agonist. CONCLUSIONS: In this study, we demonstrated that MSCs altered the immune response after acute injury in the spinal cord. In numerous assays, MSCs suppressed activation of microglia and release of the pro-inflammatory cytokine TNF. Of these assays, IMG could be standardized and used as an effective potency assay to determine the efficacy of MSCs for treating white matter disease or other neuroinflammatory conditions associated with microglial activation.

Duke Scholars

Published In

Cytotherapy

DOI

EISSN

1477-2566

Publication Date

February 2024

Volume

26

Issue

2

Start / End Page

185 / 193

Location

England

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Microglia
  • Mice
  • Mesenchymal Stem Cells
  • Macrophages
  • Leukoencephalopathies
  • Immunology
  • Humans
  • Animals
  • 3206 Medical biotechnology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Xu, L., Min, H., Saha, A., Gunaratne, A., Schwartzman, J., Parrott, R., … Filiano, A. J. (2024). Mesenchymal stromal cells suppress microglial activation and tumor necrosis factor production. Cytotherapy, 26(2), 185–193. https://doi.org/10.1016/j.jcyt.2023.11.006
Xu, Li, Hyunjung Min, Arjun Saha, Aruni Gunaratne, Jonathan Schwartzman, Roberta Parrott, Joanne Kurtzberg, and Anthony J. Filiano. “Mesenchymal stromal cells suppress microglial activation and tumor necrosis factor production.Cytotherapy 26, no. 2 (February 2024): 185–93. https://doi.org/10.1016/j.jcyt.2023.11.006.
Xu L, Min H, Saha A, Gunaratne A, Schwartzman J, Parrott R, et al. Mesenchymal stromal cells suppress microglial activation and tumor necrosis factor production. Cytotherapy. 2024 Feb;26(2):185–93.
Xu, Li, et al. “Mesenchymal stromal cells suppress microglial activation and tumor necrosis factor production.Cytotherapy, vol. 26, no. 2, Feb. 2024, pp. 185–93. Pubmed, doi:10.1016/j.jcyt.2023.11.006.
Xu L, Min H, Saha A, Gunaratne A, Schwartzman J, Parrott R, Kurtzberg J, Filiano AJ. Mesenchymal stromal cells suppress microglial activation and tumor necrosis factor production. Cytotherapy. 2024 Feb;26(2):185–193.
Journal cover image

Published In

Cytotherapy

DOI

EISSN

1477-2566

Publication Date

February 2024

Volume

26

Issue

2

Start / End Page

185 / 193

Location

England

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Microglia
  • Mice
  • Mesenchymal Stem Cells
  • Macrophages
  • Leukoencephalopathies
  • Immunology
  • Humans
  • Animals
  • 3206 Medical biotechnology